GlucoTrack, Inc. (GCTK)
0.66
+0.01
(+1.54%)
USD |
NASDAQ |
May 29, 16:00
0.65
-0.01
(-1.52%)
After-Hours: 20:00
GlucoTrack EPS Diluted (Quarterly) : -2.646 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| DexCom, Inc. | 0.5109 |
| TransMedics Group, Inc. | 0.2021 |
| AngioDynamics, Inc. | -0.1944 |
| Alphatec Holdings, Inc. | -0.2201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.334M |
| Total Expenses (Quarterly) | 4.334M |
| Enterprise Value | 0.3265M |
| Earnings Yield | -3.16K% |
| Normalized Earnings Yield | -3187.59 |